|
CYTOTOXIC AGENTS
|
|
|
|
|
Onset |
Peak |
duration |
|
Lispro |
ultrashort |
|
0-15 m |
30-90 m |
<5 |
|
Regular |
Short |
|
.5-1 |
2-4 |
5-8 |
|
Semilente |
Short |
+zinc |
.5-1 |
2-8 |
12-16 |
|
Isophane |
Intermed |
+protamine |
1-2 |
6-12 |
18-24 |
|
Lente |
Intermed |
+sinc |
1-2 |
6-12 |
18-24 |
|
Ultralente |
Long |
+zinc |
4-6 |
6-18 |
20-36 |
|
Glargine |
Very long |
|
|
|
|
MA: sulfonylurea, long acting
-binds to ATP/K channel in beta cell = Ca++ influx = incr. insulin secretion
SE: hypoglycemia, gi, skin, liver, blood problems, weight gain
Glipizide : short acting sulfonylurea
Metformin (glucophage)
MA: decr. glucose production, incr. glucose uptake by liver
SE: lactic acidosis, gi, do NOT use in renal ds
MA: decr. glucose absorption ( inhib alpha- glucosidase)
SE: flatulence, cramps, diarrhea
MA: thiasolidinedione- binds to PPAR (nuclear trans. Factor) to decr. gluconeogenesis and trigly. syn. in liver, incr. glucose uptake by muscle and adipose, decr, FA syn by adipose
SE: hepatotox, cardiovasc. Complications, check LFTs q 2 mo.
Hydrocortisone (cortisol)
MA: short acting, not selective
TU: replacement in adrenal insufficiency
SE: some mineralocorticoid effects
MA: intermediate, relatively selective
SE: less mineralocorticoid effects
Prednisone: prodrug of Prednisone
MA: intermediate
MA: long acting (less protein bound), highly selective
TU: after neuro surgery to reduce edema
MA: long acting (less protein bound)
TU: stimulate surfactant in premies
MA: meneralocorticoid selectivity
TU: 21-hydroxylase def. (primary adrenal insuff.)
Spironolactone
MA: aldosterone antangonis
TU: K+ sparing diuretic, also used for aldo secreting tumors and hisutism
MA: adrenocortical inhibitor (inhibits 11-hydroxylase)
TU: to diagnose adreanal insuff and Cushings, to treat adrenal cancer or ectopic ACTH production
MA: adrenocortical inhib, stops first step in corticosteroid syn. (ALL)
TU: Cushing s and hormone dependent tumors
MA: adrenocortical inhib, blocks heme site in p450 of 11-hydroxylase and others
TU: some use in Cushings from a malignacy
MA of glucocorticoids (anti-inflamm)
-decr. arachidonic acid metabolism, vasoconstriction and decr. perm, decr. # of inflamm cells at site, decr. cytokines and response.
SE of glucocorticoids:
-immunosuppression, muscle wasting, thinning skin, osteoporosis, Decr. growth, diabetes, weight gain, ulcers, CNS effects, cataracts, glaucoma, decr. response to stress
-edema, hypernatremia, hypokalemia, alkalosis, HTN
MA: pos. allosteric modulators = incr. affinity of GABA-A for GABA rec.
SE: drowsiness, impaired coordination, confusion, short term memory loss, blurred vision, hallucinations, paradoxical rage, FATAL with ETOH, tolerance, dependence, withdrawl, cross dependence
CI: during preg, sleep apnea, drug abuse
Long acting (phase 1oxi & 2 conj):
-Clorazepate: (prodrug) anxiety, sedative, add on for partial seizures
-Diazepam: anxiety, withdrawl, muscle relax, panic, status epi
-Flurazepam: insomnia
Short acting (phase 1 alpha hydrox &2 conj):
-Alprazolam (Xanax): anxiety, agoraphobia, pani, sedative
-Midazolam: pre-anesthetic
Triazolam: insomnia
Short acting (phase 2 conj):
-Lorazepam: anxiety, antiemetic, panic, muscle relax, st. epi, withdrawl, tremor
-Temazepam: insomnia
MA: Benzo antagonist
TU: reverse sedative effect of benzo after anesthesia or od
MA: partial 5HT agonist
TU: generalized anxiety
SE: tachycardia, palpitations, nervousness, gi, paresthsias
MA: prolongs the action of GABA, general membrane depressant, decr reticular activating systme, alters sleep patterns, inhibits excitatory neurotransmitter receptors (AMPA glut)
SE: decr. vasomotor, resp, and thermo center; tolerance, cross tol, dependence, withdrawl
CI: acute intermittent porphyria, sever liver ds, sleep apnea, drug abuse, morbilliform rash, uncontrolled pain
Thiopental*: ultra short, IV anesthetic
Secobarbital: short, hypnotic
Pentobarbital: intermed, hypnotic
Phenobarbital*: long, sedative and anticonvulsant
*: incr. excretion by alkalating urine
Flurazepam (benzo)
MA: decr. delta and REM sleep. May be more effective on 2nd night
SE: daytime drowsiness (long acting)
Temazepam (benzo)
MA: prolonged onset of action
SE: REM and insomnia rebound after chronic use discontinuation
Triazolam (benzo)
MA: ultra short
SE: REM and insomnia rebound can occur in one night, ncr. anterograde amnesia, hyperexcitability, anxiety, agitation, affective disturbances, somnambulism
Zolipidem (Ambien)
MA: acts on benzo site of GABA-A, ultra short (does not decr REM or delta )
SE: drowsiness, drugged feeling, mild rebound insomnia
Pentobarbital and Secobarbital also
MA: blocks voltage gated Na channels
TU: partial and general tonic clonic, st epi
SE: nystagmus, diplopia, ataxia, lethargy, gingival hyperplasia, hirsutism, coarsening of facial features, rash, lympadenopathy, mild peripheral neuropathy
MA: prodrug of phenytoin, no propyleneglycol or ethanol so can be given IM
MA: inc. GABA mediated Cl-
TU: partial and tonic clonic (esp. infants), st. epi, febrile sz
SE: sedation, mental dulling, paradoxical excitement, dependence, rash, decr. resp drive
Carbamazepine (tegretol)
MA: blocks voltage Na; epoxide metabolite
TU: partial and tonic-clonic
SE: nausea, diplopia, ataxia, rashes, decr. bone marrow, hyponatremia
Oxcarbazepine
MA: prodrug for 10-hydroxy-carbazepine, so no bad metabolite or autoinduction
SE: very expensive
MA: blocks voltage Na, possible incr. GABA and decr. Cl-
MA: broad spectrum
SE: inhibits metabolism of phenobarb and lamotrigine; gi, tremor, hair loss, weight gain, rash, thrombocytopenia, hepatotox esp under 2 yo
Ethosuximide
MA: blocks voltage Ca (not protein bound)
TU: absence sz
SE: gi, HA, behavior, rash, rare hematologic dyscrasnias
MA: blocks NMDA receptors, voltage Ca, Na, and incr. GABA
TU: broad spectrum
SE: anaplastic anemia, hepatic failure esp. in adults
MA: blocks voltage Na and Ca
TU: partial, possibly tonic-clonic and L-G
SE: rash (esp with valproate), dizziness, HA, diplopia, somnolence
MA: incr GABA release, blocks Na and Ca (not protein bound, no hepatic metabolism, no drug interactions)
TU: partial and tonic-clonic, mainly add-on
SE: somnlence, dizzy, HA
MA: blocks voltage Na, Incr. GABA, decr. glut
TU: add on for partial and tonic-clonic, possibly L-G
SE: somnolence, cognitive slowing, renal stones
Tiagabaine
MA: incr. GABA
TU: partial and tonic clonic
SE: CNS and weakness
MA: blocks Na and Ca; incr GABA
TU: broad spectrum
SE: renal stones and drowsiness
MA: incr GABA
TU: partial and infantile
SE: cognitive and decr. visual field
MA: incr GABA
-Diazepam and Lorazepam- st epi
-Clonazepam- infantile, myclonic, occ. Absence
-Clorazepate- add-on for partial
SE: sedation, tolerance, decr resp drive
MA: bypasses rate limiting step in dopamine synthesis, converted by dopa decarboxylase
TU: used with carbidopa to decr metabolism in perphery
SE: nausea, vomiting, anorexia, peak dose dyskinesia, cariovasc, psychiatric, sleep disturbances, on off effect phenom, loss of effect over time, interaction with vit b6 and MAOIs
CI: psychotics, angle closure glaucoma, arrythmias, melanoma
MA: aromatic aa decarboxylase inhib in periphery
TU: decr SE of levodopa by decr necessary dose
Sinemet= fixed dose of Levo & carbi
MA: D2 agonist, ergot
SE: similar to levodopa + ergot assoc ( angina, digital vasospasm, erythromelagia, edema)
DI: macrolides, caffiene, ETOH
MA: D1 &D2 agonist, ergot
TU: longer half life, used with levodopa
Pramipexole
MA: nonergot dopamine agonist with antidepressant effects
TU: can be used alone
MA: nonergot dopa agonist
SE: sudden sleep
MA: MAOI type B = decr metabolis of levodopa and dopamine without tyramine syndrome
TU: may slow progress of PD (neuroprotective)
SE: insomnia, buzz, AF, incr. SE of levodopa
DI: meperidene, tricyclics
Entacapone
MA: COMT inhibitor = decr metabolism of levodpa in periphery
SE: dyskinesia, diarrhea, may incr SE of levodopa
MA: similar to Entacapone
SE: liver toxictiy
MA: antichol (help balance Ach with dopa)
TU: reduces tremor and rigidity ( not bradykinesia)
SE: dry mouth, blurred vision, constipation, urinary retention, memory
Amantadine
MA: unknown, ? glutamate antago nist?
TU: decr tremor, bradykinesia, effects disappear over time
MA: blocks all D2 receptors
TU: treats + symptp,s
-Chlorpromazine antichol, histamine, adrenergic SE
-Iozapine
-Haloperidol EPSE
SE: incr. seizures, antichol, antihistamine, antiadrenergic, EPSE, cardio tox, sen to sun and temp, weight gain, neuroleptic malignancy syndrome
MA: dopamine selective, 5HT2 blocker
TU: treats + & - symptoms with little EPSE
-Clozapine: A10 D1 blocker, 5HT2 blocker
SE: antichol, hist, adr, weight gain, drooling, incr. temp, tachycardia, rare agranulocytosis
-Risperidone: A9 &A10 D blocker, 5HT2 blocker, alpha-1 blocker
SE: dizzy, sedation, agitation; less common- EPSE, mod hyperprolactemia, incr. weight
-Olanzapine: A10 D1-4, alpha1&2, hist
SE: dizzy, daytime sedation, weight gain; less common- agitation, mild hyperprolactemia, EPSE at high doses
Nortriptyline (palmelor)
MA: tricyclic; inhibits NE and 5HT reuptake (minor DA); also blocks hist, adr, chol
SE: antihist, adr, chol, switching,seizures
Withdrawl= Sialorrhea, Lacrimation, Urination, Diarrhea, Diaphoresis (SLUDD)
Phenelzine (Nardil)
MA: MAOi type A & B
SE: orthostatic HoTN, nausea, constipation, dry mouth, sedation, weight gain, edema, impotence, ejaculation problems, SIADH, photosens, switching, parasthesias, tyramine crisis
DI: sympathomimetics, asthma inhalants, merperidine, dopamine, ssRIs
Fluoxetine (prozac)
MA: inhib 5HT reuptake, minor NE (ssRI)
SE: 5HT2= anxiety, akathisia, agitation, insomnia, panic, sexual; 5HT3= nausea, gi, diarrheaHA; photo sens, switching, seizures, weight gain
Serotonin syndrome= confusion, hypomania, hyperreflexia, myoclonus, diaphoresis, shiver, tremor, diarrhea, incoordination
Buproprion (wellbutrin and zyban)
MA: inhib NE and DA reuptake
SE: overstimulation, HA, insomnia, nausea, agitation, HTN, rash; but little sexual dysfunction
Mirtazepine (remeron)
Ma: alpha2 antagonist (= incr. NE & 5HT), 5HT2 &3 blocker
SE: sedation and weight gain, photosens, switching
Venlafaxine (effexor)
MA: blocks 5HT, NE, DA reuptake
SE: 5HT2 and 3, photosens, switching, HTn
Nefazodone (serzone)
MA: inhib 5HT and NE reuptake; blocks 5Ht2 and alpha1
SE: 5HT3 with little sexual SE; photosens, switching
MA: weak bases neutralize acid, reduce pepsin activity, protective effects
TU: duodenal ulcers
SE: inpleasant tast, large volume needes\d, Mg laxative & ALOH constipating, cation absroption problems, systemic alkalosis, Na content prob in CHF, may alter absroption of other drugs
Cimetidine (tagamet)
MA: H2 receptor antagonist
TU: duodenal and gastric ulcers, Z-E syndrome, GERD
SE: diarrhea, confusion esp in elderly, reversible gynecomastia, dose dependent incr prolactin, alters estrogen metabolism in men, in hibits CYP450
Ranitidine (zantac)
MA & TU: same
SE: HA in 34%
Omeprazole (prilosec)
Ma: proton pump inhib (prodrug)
TU: gastric & duodenal ulcers, GERD, hypersecretory conditions
SE: gi, gastrin dependent hyperplasia, inhib of drug metabolism
MA: prostaglandin E agonist, decr. acid secretion
TU: prophylaxis for extendend NSAID use
SE: dose dependent diarrhea, nausea
CI: in pregnancy
MA: gels at ph<4 and binds to necrotic tissue
SE: constipation ( aluminum), dry mouth, binds some drugs
Bismuth Subsalicylate (pepto bismol)
MA: antimicrobial., binds to ulcers, inhibits pepsin, stimulates mucous secretion
SE: staining of oral and anal tissues, tinnitus
Clarithromycin + Amoxicillin + Lansoprazol (ppi)
TU: H. pylori
SE: nausea, diarrhea, dizzy
GI MOTILITY DRUGS
MA: synthetic opiod; (penetrates CNS poorly)
TU: diarrhea
SE: some abuse potential ( so atropine added to discourage abuse)
MA: synthetic opiod, highly specific fo gi receptors; antisecretory at low doses
TU: diarrhea
SE:
MA: peptide analog of Somatostain; antisecretory
TU: some hypersecretory tumors and AIDS diarrhea
SE: nausea, gi upset with short term use
Psyllium (metamucil)
MA: incr fecal mass to stimulate stretch receptors; promotes fluid retention in feces
TU: constipation
SE: allergic rxns, flatulence, obstruction, impaction (drink full glass of H2O)
MA: osmotic laxative
TU: constipation
SE: avoid us in CHF, renal impairment, elderly; excessive evacuation possible
Ma: osmotic; safe
MA: detergent that favors fluid retention
Phenolphythalein (stimulant)
MA: promote accumulation of water, stimulates peristalsis, complex mechanisms
SE: cramping, vomiting, electrolyte disturbances, fat malabsorption, dependence, allergic rxns, carcinogenicity
MA: stimulant laxatives
MA: inhibit prostaglandin and leukotriene syn (COX)
TU: I nflamm bowel dz
SE: gi upset, malaise, allergic rxns, immune suppression
MA: antiinflamm
TU: IBD
SE: lots!
MA: monoclonal ab to TNF
TU: IBD
SE: allergic rxn, immune suppression
MA: 5HT3 antagonist
TU: during chemo and radiation
SE: transient- HA, gi, constipation, lightheadness, sedation, dizziness
MA: D2 antagonist, prokinetic, at high doses blocks 5HT3 receptor
TU: antiemetic
SE: antidopaminergic (extrapyramidal, anxiety, depression)
Chloroquine
MA: accum. In food vacuole & interferes with polymerization of heme and detox of reactive oxygen
TU: erythrocytic forms & entaemoba histolytica
SE: if given IV- HoTN, vasodilation, EKG abnormalities ; gi, mild HA, utricaria, pruritis, visual disturbances; prolonged doses- severe visual and cardiac rxns
CI: liver dz, gi, neurologic or blood disorders, G6-PDH def, preg
MA: similar to above
TU: blood schixonticide; esp for chloroquine R faciparum
SE: gi, cinchonism (tinnitus, HA, nausea, hearing and visual disturb), hyperinsulinemia, severe HoTN (IV), hemolysis in G6-PDH def
CI: preg, G6-PDH def, hypersens, cardiac arrhythmias, tinnitus, optic neuritis
MA: inhib. Dihydropteroate syn (sulfadoxine) and inhib dihydrofolate reductase (pyrimethamine)
TU: blood schixonticide for chloroquine R in one dose self tz
SE: rashes, decr. hematopoiesis, megaloblastic anemia, erythema multiforme & S-J rash
MA: converted to electrophiles that interfere with ETC in parasite
TU: late HEPATIC stage
SE: large doses- gi, nausea, HA; hemolyic anemia, cyanosis, leukocytosis
CI: preg and G6-PDH def
MA: similar to quinine
TU: blood schizonticide and prophylaxis of choloroquine R and MDR falciparium
SE: gi upset, CNS tox, rare neuropsychiatric disturbances
MA: may produce free radicals
TU: blood schizonticide for all types
SE: abd pain, diarrhea, emrytox
TU: used in conjunction with other antimalarial agent s for tx in MDR regions and prophylaxis
MA: unknown ? direct amebicide
TU: luminal amebicide for asymptomatic cyst passers
SE: subacute myelo-optic neuropathy
MA: chemical reduction of nitro gp within parasite by ferredoxin produces reactive metabolite which damaged DNA
TU: DOC for all symptomatic cases (must be given with luminal agent)
SE: mild gi, occ neuro tox, disulfiram like effect (ETOH)
MA: inhib of microtubule polymerization by binding tubulin (poorly absorbed)
TU: broad spectrum antihelmintic, esp for mixed inf
SE: transient abd pain and cramping, teratogenic
MA: inhib of microtubule polymerization
TU: cutaneous laval migrans (canine hookworm); alternative for Strongyliodes
SE: gi, CNS, fever, rash, potential hepatotox
MA: interferes with Ca homeostasis, spastic paralysis, tegument damage and activation of host defenses
TU: DOC for shistosomiasis, trematodes, cestodes
SE: gi, CNS
MA: potentiation of glutamate Cl- channels in invertebrates
TU: onchocercisis, filariasis, nematodes
SE: mazotti-like rxn (fever, pruritis, dz, edema); minimal ocular inflamm
MA: allopurinol & active metabolite (oxypurinol) inhib xanthine oxidase = decr. uric acid
TU: hyperuricemia; ihib perfusion injury of transplants
SE: gi, drowsiness, HA, metallic taste, allopurinol hypersens synd (rash, pruritis, gi, fever, hep-renal tox), incr. freq of acute attacks, drug interactions
MA: uricosuric agent (blocks tubular reabsorption of uric acid )
SE: gi (no effect if taken with aspirin!), incr. frequency of acute attacks, drug interaction
CI: if history of renal lithiasis, >800mg of uric acid excreted per day, GFR<55 ml/min
MA: uricosuric agent
SE: gi, ulcers, inhib thrombaxane syn and platelet formation, no effects if taken with aspirin, displaces warfarin, asp, and oral hypoglycemics
CI: same
MA: prevents formation of microtubules for leukocytes to migrate along, inhib release of chemotactic factors
TU: diagnositic aid, acute attack IF NSAIDS CI, to prevent recurrence
SE: gi (stop if you see this), if OD- liver tox, kidney tox, bone marrow depr, allopecia; if IV- tissue necrosis; hypersens. Rxn
TU: actue attack and inflamm
SE: HA, gi
MA: GABA-B agonist
TU: decr. spasticity from MS & spinal cord injury; hiccups; neuropathic pain
SE: drowsiness, insomnia, dizzy, weakness, ataxia, mental confusion, gi, withdrawl (hallucinations, anxiety, tachycardia, rebound flexor spasms); toxic ( coma, resp depr, seizures)
MA: GABA-A Cl- channels (decr. excitatory neurotrans)
TU: decr. spasticity esp for spinal cord injuries; occ for cerebral palsy; muscle spasms
SE: more sedation, impaired coordination, weakness, dz, confusion, ataxia; withdrawl ( dysphoria, irritability, sweating, unpleasant dreams, tremors, anorexia); toxic (drowsiness, ataxia, dysarthria, areflexia)
MA: decr Ca+ release from sarcoplasmic reticulum; little effect on cardiac and smooth muscle; decr. reflex rather than voluntary contraction
TU: decr spasticity in UMN lesions including stroke; prevent or tx malignant hypterthermia and neuroleptic malignant syndrome
SE: will developtolerance to : drowsiness, dz, malaise, fatigue, diarrhea ; WEAKNESS; hepatotox
MA: decr polysynaptic feflexes and facilitative and inhib neurol activity affecting stretch reflexes
TU: short term tx of muscle spasms and pain
SE: drowsiness, dryness of the mouth, dz; other antichol; large doses- areflexia, flaccid paralysis, resp depr, tachycardia, HoTN
CI: acute MI, arrhythmias, CHF
MA: same
TU: discomfort caused by spasms
SE: drowsiness, incoordination, dz, discoloration of urinem gi, hypersens, blurred vision,; if IV- syncope, HoTN, bradycardia, ataxia, vertigo, seizures, hemolysis; large doses- CNS and resp depr
NSAIDS also used for muscle spasms
TU: muscle paralysis for surgery, during ECT, artificial ventilation
CI: muscle dz (ALS, myasthenia gravis), burns
DI: all of the following increase NMB: antibiotics, anesthetics, barbs, quinidine, Ca channel blockers
d-Tubocurarine
MA: competitive blocker at nicotinic Ach receptor
SE: HoTN caused by: histamine release and blockade of ganglionic receptors
MA: same
SE: blocks muscarinic receptors in the heart = tachycardia and slight HTN; minor effect of blocking NE reuptake
MA: phase I block= nicotinic receptor agonist (not metabolized by AchE)- accomodation= flaccid; phase II block = after large dose Ach receptor is desensitized
SE: in low dose (children): stimulates muscarinic rec in heart= neg. inotropic and chronotropic , can be prevented with atropine; in high dose (adults): stimulates nicotinic rec in autonomic ganglia = arrhythmias and HTN; may cause malignant hyperthermic crisis; do not use if atypical plasma choinesterase
MA: block Na+ channels along axon (ioniozed form is active; can be given with Epinephrine to reduce uptake)
SE: vasodilation (except cocaine), bradycardia, CNS effects, hypersensitivity
Benzocaine: Paraaminobenzoic acid ester, no hydrophilic gp = topical
Procaine: para aminobenzoic acid ester
Cocaine: benzoic acid ester
Lidodaine: amide
MA: barb
TU: induction (30-60 sec; duration 5min, half life=11.5 hrs)
SE: HoTN, decr myocardium, TPR, resp; antianalgesic
MA: pot. GABA, GABA agonist at high conc
TU: induction, maintenance, sedation in ICU (11sec, duration- 8 min; half life- 1hr)
SE: HoTN, decr TPR, resp
MA short acting benzo
TU: calm patient; decr amt of anesthetic needed
SE: decr resp in elderly
MA: opiod analgesic
TU: general anesthesia (neurolepthanesthesia)
MA: Least lipid soluble (incr. MAC); least aqueaous sol (fastest)
TU: good analgesic with very little effect on resp and heart
SE: degree of CNS depression and muscle relax is limited
Halothane (most potent)
MA: very lipid sol (decr MAC), very aquesous sol (slow induction); can be given with N2O for second gas effect
SE: resp depr, decr cardiac output (sensitizates the heart), poor analgesic and muscle relax, malignant hyperthermia, autoimmune hepatitis
MA: les aq and lipid sol than halothane
TU: adequate muscle relax and some analgesia
SE: dec BP, TPR, resp; incr HR; malignant hyperthermia
TU: adequate muscle relax
SE: decr TPR, BP, CO, resp, malignant hyperthermia, release offree Fl-
TU: skin ulcerations, burns, frostbite, preserving circ, dieters tea
MA: antimicrobial, antineoplastic, antiiinflamm, and bradykinase
SE: ARF, derm rxns, hypokalemia with prolonged use
TU: decr chol and BP; antiCA
MA: cardiovasc, antimicrobial, antineoplastic effects
SE: heartburn, flatulence, malodorou breath and skin, possible antiplatelet effects
TU: tonic, performance enhancer, aphrodisiac, adaptogen, antiCA
MA: incr neurotrans, potentiates 5HT, may pot. GABA, inhib cAMP phosphodiesterase
SE: weak estrogenic (vaginal bleeding, mastalgia), ginseng abuse syn, CNS stim and HTN in high does, hypoglycemia
DI: with digoxin and warfarin, caution with psychiatric, estrogenic, hypoglycemic drugs
CI: in preg,
TU: sedative, spasmolytic, antiinflamm, wound healing
MA: antineoplastic, decr inflamm, binds benzo receptors
SE: allergies
DI: avoid other sedatives
TU: mild sedative, sleep aid, anxiolytic
MA: inhib GABA breakdown, binds to GABA-A, may bind benzo receptor, direct smooth muscle relzx, antiarrhythmic and coronary art dilation, cytotoxic to granulocyts, macrophages, lymphs, RBCs
SE: liver damage, rare HA, rare palpitations
CI: in preg and with other sedatives
TU: mood disorders, weight loss
MA: MAOi, ssRI, NERi, DARi, antiviral, antiCA
SE: allergic rxns, photosens, gi, hypomania, mania, dizziness, confusion
CI: in preg, with other psychoactive drugs; induces CYP3A4 and glutathion-S transferase (= decr. warfarin, clozapin, olanzapine, etc.)
TU: anxiety, stress, sedative, centrally acting muscle relaxant
MA: alters limbic modulation, MAOi (b), antiplatelet effects
SE: tingling in mouth, gi upset, CNS effects (euphoria, visual, auditory), dermopathy
CI: with other depressants, dopamine agonists/antagonists, benzos, in preg
TU: liver dz and cirrhosis
TU: prophylaxis of viral URI, wound healant
MA: immune modulation, inhibs COX and 5-lipoxygenase
SE: mild allergic rxns, flu-like, unpleasant taste, gi upset
TU: perimenopausal and postmenopausal symptoms
MA: may suppress LH levels and bind to estrogen receptors
SE: occ gi
CI: in preg and lactation
TU: HRT and decr breast and endometrial CA
MA: high affinity for estrogen receptors with low activity
SE: none reported
TU: BPH and to improve reproductive functioning
MA: antiandrogenic, -estrogenic, -inflamm, -androgen; 5alpha reductase inhib, COX and 5-lipooxygenase inhib
SE: mild HA, gi upset, HTN, impotence, decr libido
TU: dementia and diabetes circulatory problems
MA: incr blood flow, decr blood viscosity, incr NO, superoxide dismutase-like activity, blocks chemotactic factors, modifies CNS neurotrans, PAF antagonist
SE: nauseau, HA, allergy, anxiety, insomnia, hemorrhage, ingestion of seeds can cause death
DI: antiplatelet and anticoag meds
TU: migranes, antiarthritic
MA: inhib 5HT release from platelets and WBCs, vasodilation, decr inflamm, inhib phagocytosis, platelet agg, and inflamm mediators
SE: gi, dz, oral ulcers, rebound HA with discontinuation
CI: in preg and coag problems
TU: Ocs, hypogonadism, hypopit, HRT (vasomotor disturbances, urogenital atropy, psychological, osteoporosis, heart dz (dec LDL, incr HDL), alzheimers), given with progestins to decr endometrial ca risk
SE: nausea, edema, breast enderness, hyperpig, HA, HTN, cholestasis, gall bladder dz, thrombophlebitis at high doses, endometrial hyperplasia and CA if given alone, gynecomastia and feminization in men
Estradiol: oral (rapid first pas metabolism), depot, topical
Conjugated Es (Premarin): oral, IV, Vaginal; major use in HRT
Ethinyl Estradiol: ethinyl gp greatly slows metabolism; used in Oral Contraceptives
Mestranol: prodrug of ethinyl estradiol, used in Ocs
Alendronate (fosamax) (NOT AN ESTROGEN)
MA: nonsteroidal bisphosphonate that decr bone resoption
TU: postmenopausal osteoporosis
MA: nonsteroidal mixed agonist/ antagonist
TU: breast CA, breast CA prophylaxis, beneficial effects on osteoporosis & lipids
SE: incr endometrial CA risk, incr thrombosis risk
Raloxifen (Evista)
MA: SERM
TU: beneficial effects on breast , uterus, bone, lipids
SE: ? agonist for clotting
Clomiphene (Clomid)
TU: stimulate ovulation
MA: blocks feedback receptors and incr. gonadotropin release
SE: mult births, ovarian cysts and enlargement, hot flashes
TU: endometriosis, fibrocystic breast changes
MA: inhib gonadotropin secretion and steroid syn, weak androgen and progestin activity
TU: breast CA, endometriosis, uterine fibroids, PCO; prostate CA, hirsutism, precocious puberty
MA: GnRH agonist ( initially stimulates gonadotropin release but then desensitizes the GnRH receptors and decr. gonadotropins)
TU:alone or with E for contraception, with E for HRT, DUB due to endometrial hyperplasia, endometriosis, pallation in metastatic endometrial and breast ca, diagnosis of strogen secretion and endometrial responsiveness
SE: mentral changes, nausea, bloating, teratogenesis, androgenic (acne, weight gain, masculinization, decr. HDL and inc LDL)
Progesterone: IM, cream, suppositories, IUD, oral
Medroxyprogesterone acetate: Provera= replacement; Depro-Provera= contraception (can have delayed recovery of fertility); chemical castration in males
Norgestrel & Norethindrone Acetate: structurally related to testosterone; used in Ocs; lack of regular menstration, still have ovulation but affects implantation when used alone
Levonorgestrel (Norplant)
TU: birth control for 5-6 yrs, fertility returns to normal
SE: visible under skin, irregular bleeding
MA: progesterone ANTAGONIST; disrupts endometrium maintence; stimulates prostaglandin levels slightly
SE: vaginal bleeding, cramps, nausea, vomiting, diarrhea, HA
Emergency Contraceptive Kit
-4 tablets with mod high doses of Ethinyl estradiol and levonorgestrel (2ASAP, 2 12 hrs later) ; OR 2 pills of levonorgestrel within 72 hrs
Clomiphene: see antiEs
TU: infertility due to excess prolactin
MA: dopamine agaonist (inhib prolactin secretion)
Human Chorionic Gonadotropin (hCG)
TU: induce ovulation and hypogonadism
MA: very similar to LH (not orally effective)
Menotropins (hMG)
TU: with hCG to induce ovulation
MA: LH and FSH activity
SE: ovaria hyperstimulation, mult births, cyst enlargement
TU: induce ovulation when defect in hypothalamus
MA: pulsatile synthetic GnRH (like leuporlide, but pulsatile)
TU: induce and augment labor, restore uterine tone after delivery, enduce milk let down
MA: stimulates smooth muscle contraction, elicits milk ejection, constricts umbilical arteries and veins (but high doses relax HoTN), stimulates prostaglandins contraction
TU: 2nd trimester abortions with RU486, cervical ripening at low conc
MA: stimulates uterine contractions
SE: diarrhea, vomiting, vasoconstriction, fever
TU: post partum to control bleeding and maintain uterine contractions
MA: incr frequency and force of uterine contractions, constrict vascular smooth musc
SE: forceful contractions
CI: in HTN
MA: beta-2 adrenergic receptor agonist (IV & oral)
TU: delay delivery
SE: reflex tachycardia, incr cardiac output, can induce hyperglycemia, bronchodilation
MA: blocks Ca++ effects
TU: m. sulfate- IV to inhibit uterine motility and control eclamptic seizures; m. gluconate- orally for tocolysis maintenance
SE: high conc= resp depression and cardiac arrest
TU: hypogonadism, hypopit, muscle wasting dz, antiestrogen in breast CA, promote erythropoiesis
SE: hirsutism, deep voice, clitoral enlargment, decr breast size, baldness, feminization in men, testicular atrophy, oligospermia, prostate enlargement, in cr risk of prostate CA, acne, liver dz, liver tumors (esp 17-alkyl), salt and H20 retention, HTN, psychosis, androgen rage
Testosterone- transdermal patches, pellets, gel
Testosterone esters- IM
Methyltestosterone- (17-alkyl); oral, HEPATOTOXIC
MA: GnRH analog (initially stimulates gonadotropin release but then desens receptors)
TU: prostate CA; breast CA, endometriosis, fibroids, PCO
MA: nonsteroidal androgen receptor antagonist
TU: prostate CA, hirsutism in women
MA: antagonist at mineralocorticoid and androgen receptor
TU: alone or with Ocs for hirsutism in women; diuretic
Finasteride (propecia)
MA: 5 alpha reductase inhib (blocks Ts conversion to DHT)
TU: BPH and male pattern baldness
Lovastatin
MA: HMG CoA reductase inhib = incr hepatic LDL receptors, also may decr inflamm at plaque site
TU: decr LDL, TGs, inc HDL (often used with BABR)
SE: gi, HA, rash, liver problems, myopathy; CI in preg
Gemfibrozil (fibric acid)
MA: binds PPAR- gamma =incr lipoprotein lipase= incr VLDL catabolis & decr Apo C II may also decr FA incorp into TGs
TU: decr VLDL and incr HDL (types III, IV, V)
SE: gi, rash
CI with statins - may incr myopathy
MA: bile acid binding resin = decr reabsorption of bile acids leads to decr feedback inhib of the enzyme converting chol to bile acid = incr breakdown of hepatic chol = incr HMG CoA reductase and incr LDL receptors
TU: decr LDL, incr HDL (type Iia)
SE: constipation, mild steatorrhea, will bind other drugs
Nicotinic Acid (niacin)
MA: decr VLDL synthesis via lipolysis inhib in adipose; decr esterification of TGs in liver, incr lipoprotein lipase = decr IDL, LDL, and incr HDL
TU: rapidly decr VLDL, slowly decr LDL, incr HDL = decr TGs
SE: intense cutaneous flush and pruritus, gi, hepatic, peptic ulcers, hyperglycemia, hyperuricemia
CI: preg, hepatic dz, ulcers, gout
Class I = Na+ channel blockers (fast tissue)
Ia= Na+ and Ca++ (uinidine, Procainamide, Disopyramide)
Ib = Na+ (Lidocaine)
Ic: potent Na+ and variable beta (Propafenone)
Class II = Beta blockers (slow tissue) (Propranolol)
Class III = K+ channel blockers (fast) (Amiodarone, Bretylium, Sotalol)
Class IV = Ca++ channel blockers (slow) (Verapamil)
MA: class Ia, antimuscarinic, alpha NE blocking
TU: supravent and vent arr
SE: SA block, torsade de pointes, in AF paradox. Incr in vent rate, asystole or arr if QRS >30% wider; conchonism (tinnitus, dz, blurry, HA), gi, incr digoxin, if IV HoTN
Procainamide
MA: class Ia, proarrhythmic metabolte NAPA
TU: supravent and vent arr
SE: similar to quinine but less tdp, HoTN with rapid IV, drug induced lupus (esp in slow acetylators)
MA: class Ia, antimuscarinic, Ca++ channel blocker
TU: supra vent and vent arr
SE: same as quinidine but incr antimuscarinic, negative inotropic
MA: class Ib (little effect on normal tissue and atria, does NOT widen QRS)
TU: vent tachy/ arr following MI, surgery, or cardiov ersion
SE: CNS (paresthesis, drowsiness), toxic levels = convulsions, hearing disturbances, resp arrest
MA: class Ic, variable beta blocker
TU: life threatening vent arr (AF, SVT)
SE: proarrhythmic
MA: class II, at high conc direct effect on Na & K, affects regulation of Ca &K channels
TU: vent arr due to exercise/ emotions, after MI, supravent arr (AV nodal reentry)
SE: may incr CHF due to decr contraction BUT decr mortality in mild CHF; SA and AV block, sudden withdrawl may incr angina and arr
MA: class III (incr vent, transient incr NE followed by decr NE)
TU: drug R VF or sustained VT (chemical defib)
SE: HoTN
MA: class III, Na block, Ca block, beta block
TU: prevent recurrent VF/VT (half life is 1-2 months!)
SE: pulmonary fibrosis, hepatic tox, photosens,neuro, thyroid, (? Blue discoloration of face?)
CI: with many other antiarr drugs esp beta blockers and Ca blockers
MA: class III and beta blocker
TU: supra vent and vent arr
SE: tdp
Verampamil
MA: class III & beta blocker
TU: COD for supra vent tachycardia due to AV nodal reentry; also for AF
SE: CI in severe heart failure, HoTN, sick sinus syndrome, AV block, VT , WPW synd;
Constipation, nausea, peripheral edema, if given with beta blockers or digitalis- bradycardia or AV block
ME: opens K+ channels and hypopolarizes AV nodal tissue
TU: paroxysmal supravent tachy
SE: very short time of action (seconds)
MA: direct positive inotropic effect (inhibits Na/K/ ATPase = incr Ca++); indirect incr in parasymp
TU: CHF & AF
SE: vent extrasystoles (DAD), SA & AV block, A V junctional rhythum (triggered activity), toxic levels - stim sympathetics; gi, neuro
MA: thiazide diuretic, inhibits NaCL reabsorption
MA: ACEi
SE: dry cough, ARF
MA: ACEi (prodrug & longer acting)
MA: AT receptor antagonist
SE: HoTN, gi
MA: similar to losartan
SE: dizziness
MA: Ca++ channel blocker
- less cardiac depression
MA: nonselective beta antagonist
MA: beta 1 , beta 2, and sympathomimetic activity
MA: blockade of alpha1, beta 1, beta 2
MA: alpha adrenergic receptor blocker
MA: CNS alpha 2 adrenergic receptors = decr symp & incr parasym
SE: dry mouth, sedation, impotence, withdrawl
MA: acts on medulla oblongata = decr sympathetic = NaCl and H2O retention
SE: sedation, CNS effects, + Coombs test
MA: arteriolar dilation (?unknown mech)
SE: HA, sweating, reflex tachycardia
MA: dilates arteries and veins
SE: cyanide accumulation (arrhythmias, HoTN)
MA: dilates arteries, opens K+ channels
TU: HTN emergency
SE: HoTN
MA: incr NO = incr cGMP = myosin light chain dephosphorylation = relaxation of veins = decr VR = decr preload; & dilation of coronary arteries
SE: reflex tachycardia, relax of other smooth muscles, tolerance can develop
DI: dildenafil (viagra) = severe HoTN
MA: longer acting
MA: Ca++ channel blocker = arterial relax = decr afterload; & dilation of coronaries
SE: reflex tachycarida (could aggrevate angina at high doses, HA, HoTN, dizziness, rash, somnolence, gi
MA: Ca++ channel blocker & negative inotropic, chronotropic, dromotropic (therefore no reflex tachycardia)
SE: cardiac depression, constipation
MA: beta adrenergic receptor antagonists (neg inotrope and chronotrope)
|
Receptor |
Response |
|
Muscarinic |
s.m. contraction , decr HR, gland secretion |
|
Nicotinic |
Gang. Stim, skeletal muscle contraction |
|
Alpha 1 |
Vasoconstriction, pupil constriction, decr gi cont |
|
Alpha 2 |
Decr NE release |
|
Beta 1 |
Incr HR, incr ontractility, incr automaticity |
|
Beta 2 |
Vasodilation, bronchodilation |
|
Dopamine |
Renal and mesenteric vasodilation |
|
Oragan |
Predom tone |
Effect of blocking ganglion |
|
Arterioles |
S |
Vasodilation |
|
Veins |
S |
Peripheral pooling |
|
Heart |
P |
Tachycardia |
|
Iris |
P |
Mydriasis |
|
Ciliary muscle |
P |
Cycloplegia |
|
Gi |
P |
Constipation |
|
Bladder |
P |
Urinary retention |
|
Salivary glands |
P |
Dry mouth |
|
Sweat glands |
P |
Increased body temp |
|
ORGAN |
SYMP (Epi & NE) |
PARASYM (Ach) |
|
Bronchiole |
Relax beta 2 |
Contract musc |
|
Radial muscle |
Contract alpha 1 |
- |
|
Spincter muscle |
- |
Contract musc |
|
Ciliary muscle |
- |
Contract musc |
|
Gi walls |
Relax alpha 1, beta2 |
Contract musc |
|
Gi spincter |
Contract alpha 1 |
Relax musc |
|
Gi secretion |
- |
Increased- musc |
|
|
Relax beta 2 |
Contract- musc |
|
Bladder spincter |
Contract alpha 1 |
Relax musc |
|
|
Relax beta2; contract alpha 1 |
- |
|
Penis |
Ejaculate- alpha1 |
Erection musc |
|
Heart |
Increase beta 1 |
Decrease musc |
|
Sweat glands |
Increase musc |
- |
|
Skin vasculature |
Contract alpha 1 |
- |
|
|
Relax beta2; contract alpha 1 |
- |
STIMULATES M BLOCKS M
-Bethanechol (bladder) -Atropine (CNS)
-Scopolamine
-Ipratropium (bronchioles)
-Tropicamide (iris)
STIMULATES M &N BLOCKS M&N
-Ach -Botulism toxin
-Pilocarpine (ciliary)
-Physostigmine (CNS)
-Donepezil (Alsheimers)
-Rivastigmine (Alzheimers)
AchE INHIB AT M&N AchE REACTIVATOR AT N
-Neostigmine (also stimulates N) -Pralidoxime
-Edrophonium
-Echothiophate
-Parathion
-Isoflurophate
STIMULATES ALPHA1 BLOCKS ALPHA1
-Phenylephrine -Prazosin
-Phenylpropanolamine
STIMULATES ALHPA2 BLOCKS ALPHA2
-Clonidine
STIMULATES BETA1 BLOCKS BETA1
-Dobutamine -Metoprolol
STIMULATES BETA2 BLOCKS BETA2
-Terbutaline
-Ritodrine (uterus)
STIMULATES BETA1&2 BLOCKS BETA1&2
-Isoproterenol -Propranolo
-Timolol
BLOCKS UPTAKE OF NE BLOCKS DA UPTAKE
-Cocaine = decr NE
-Imipramine -alpha methyldopa
-Reserpine
-Tyramine
-Amphetamine